Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4104 Promising outcomes with surufatinib-vinorelbine combination therapy in lung cancer with neuroendocrine differentiation

Introduction: Lung cancer (LC) remains one of the most prevalent and deadly cancers worldwide. Neuroendocrine differentiation (NED) is observed in 25-33% of LC cases. NSCLC patients with NED (NSCLC-NED) often have worse outcomes, resembling SCLC behaviour.

Conference:

Presenting Author:

Authors: Chai M, Zhang Y, Wang Y, Lu Z, Xie J,

Keywords: NSCLC-NED, treatment, surufatinib, vinorelbine,

#2914 Safety Profile and Adverse Events of Special Interest for Surufatinib in Chinese Patients with Advanced Extra-Pancreatic Neuroendocrine Tumors: Analysis of the Phase 3 SANET-ep Trial

Introduction: The previously reported SANET-ep trial (NCT02588170) demonstrated surufatinib significantly improves progression-free survival (PFS) in patients (pts) with advanced extrapancreatic neuroendocrine tumors (epNETs) compared to placebo; median PFS (9.2 vs. 3.8 months; HR = 0.334, 95% CI 0.223 to 0.499, p

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Li J

Authors: Li J, Xu J, Zhou Z, Bai C, Chi Y,

Keywords: extra-pancreatic, neuroendocrine tumors, safety,

#1771 Nomogram Individually Predicts the Overall Survival of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms

Introduction: A few previous studies have shown that nomograms can predict the survival rates of patients with neuroendocrine neoplasms (NENs).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Wei W

Authors: Wei W, Cheng F, Jie C, Zhiwei Z, Ye C,

Keywords: Gastroenteropancreatic Neuroendocrine Neoplasms, Nomogram, Prognosis,

#1768 Patterns of Treatment and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs): Results from Multicenter Database of China

Introduction: The multicenter studies of large-volume database about gastroenteropancreatic neuroendocrine neoplasms(GEP-NENs) patients is rare in China.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Cheng F

Authors: Cheng F, Wei W, Zhiwei Z,

Keywords: gastroenteropancreatic neuroendocrine neoplasms, treatment, prognosis, China,

#1431 Expression of Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Neoplasm and Multicenter Retrospective Clinical Study of Octreotide LAR in the Treatment of Advanced GEP-NET

Introduction: Gastroenteropancreatic neuroendocrine neoplasms(GEP-NENs) are known to overexpress somatostatin receptors(SSTRs),which forms the basis for octreotide long-acting repeatable(LAR) treatment in NEN.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Jie C

Authors: Yuhong W, Wei W, Kaizhou J, Cheng F, Zhiwei Z,

Keywords: gastroenteropancreatic neuroendocrine neoplasm, somatostatin receptor, octreotide, treatment,